Congress Instructs FDA On Nanotech Work, But Mute On Funding
This article was originally published in The Rose Sheet
Executive Summary
Newly passed user-fee legislation includes a provision directing FDA to intensify its research and policy development regarding nanotechnology and its use in consumer products. How such efforts are to be funded remains a question.